top of page
24973725_xl_normal_none_edited.jpg

Leading the Fight Against

African Swine Fever Virus

AI-Driven Vaccine &
Antibody Development

OUR STORY

At Kermode Biotechnologies, we are dedicated to pioneering solutions in animal health, with a focus on combating the African Swine Fever Virus (ASFV). Founded on the principles of innovation and scientific excellence, our team is developing novel vaccines that leverages unique protein antigen subunits to elicit strong immune responses in swine. With roots in both New York and Shenzhen, we bridge the gap between cutting-edge research and practical applications. Our mission is to safeguard global swine populations, enhance food security, and support farmers worldwide. Through relentless pursuit of groundbreaking research, Kermode Biotechnologies stands at the forefront of animal disease prevention, transforming challenges into opportunities for a healthier future.

ABOUT

AFRICAN SWINE FEVER VIRUS

The spread ASFV has devastated the commercial swine industries in Europe, Russia, and most recently China, resulting in billions of lost dollars and the loss of a major nutritional staple. It is a matter of time before ASFV infiltrates North American livestock.

Picture17.png

ASFV is a highly contagious
viral pathogen that swiftly
infects swine livestock.

Picture19.png

Once the swine are infected, the virus
will kill the animal within
24 to 48 hours.

Picture22.png

The mortality rate for
ASFV-infected animals is
100%.

ASFV STATISTICS

OUR APPROACH

We are utilizing computational approaches to define vulnerable targets in viral structure, genetic composition and replication cycles. Once these targets are defined, we deploy state-of-the-art antibody discovery platforms to isolate therapeutic candidates with the highest potential to protect livestock against viral infections. This approach will allow Kermode to identify strong antibody therapeutics and construct vaccine candidates with long-lasting in vivo responses.

Picture35.png
ASFV Antibody
Picture38.png

Regulatory
Submission

Partnering

ANTIBODY AND ANTI-VIRAL PROTEIN DEVELOPMENT FOR THERAPEUTICS / VACCINES

ANTIBODY & PROTEIN INVENTION

ANTIBODY & PROTEIN CHARACTERIZATION

PROTEIN EXPRESSION

SWINE STUDIES

MARKET APPROVAL

ASFV THERAPEUTIC
DEVELOPMENT PIPELINE

OUR PARTNERS

At Kermode Biotechnologies, we believe in the power of collaboration to drive innovation and success. Our partners play a crucial role in advancing our mission to develop cutting-edge solutions for the prevention and control of the African Swine Fever Virus (ASFV). By working together, we leverage each other's strengths, expertise, and resources to accelerate the development and distribution of our groundbreaking vaccine technology.

Dual Systems
Bruker

By partnering with industry leaders in biotechnology, pharmaceuticals, and animal health, we enhance our capabilities in research, development, and manufacturing. These partnerships allow us to scale our production processes and ensure the availability of our vaccine to swine herds across the globe.

KERMODE BIOTECHNOLOGIES IN THE NEWS

Newspaper

June 3rd, 2024 - Kermode to Present at the Kansas City Animal Health Corridor Summit - August 26th - 27th, 2024 

Newspapers

Feb. 4th, 2023 - Kermode Enters into Receptor Discovery Agreement with Dual Biosystems AG

Morning Newspaper

May 15th, 2021 - Former Pharma Executive, Dr. Ed Robb Joins the Kermode Executive Team as Chief of Regulatory and Veterinarian Affairs Officer

bottom of page